Sinopharm Group Co. Ltd. (HKG:1099)
18.35
+0.17 (0.94%)
Sep 29, 2025, 4:08 PM HKT
Sinopharm Group Market Cap
Sinopharm Group has a market cap or net worth of 57.26 billion as of September 29, 2025. Its market cap has increased by 7.56% in one year.
Market Cap
57.26B
Enterprise Value
161.61B
Revenue
630.98B
Ranking
n/a
PE Ratio
7.65
Stock Price
18.35
Market Cap Chart
Since September 23, 2009, Sinopharm Group's market cap has increased from 40.42B to 57.26B, an increase of 41.66%. That is a compound annual growth rate of 2.20%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 26, 2025 | 56.73B | -14.65% |
Dec 31, 2024 | 66.47B | 4.16% |
Dec 29, 2023 | 63.82B | 3.07% |
Dec 30, 2022 | 61.91B | 16.98% |
Dec 31, 2021 | 52.93B | -10.07% |
Dec 31, 2020 | 58.86B | -30.29% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
BeOne Medicines AG | 279.26B |
Hansoh Pharmaceutical Group Company | 210.92B |
JD Health International | 206.50B |
Innovent Biologics | 159.71B |
WuXi Biologics | 158.73B |
Sino Biopharmaceutical | 142.12B |
Akeso | 122.24B |
Sichuan Kelun-Biotech Biopharmaceutical | 113.38B |